Project Grant HT94252410665
- The Defense Health Agency awarded a $755,001 Project Grant to The Medical University of South Carolina (MUSC) under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, running from July 1, 2023 to June 30, 2026, supports research on microsomal glutathione transferase as a new target in melanotic melanoma. As a public institution of higher education, MUSC conducts biomedical research and provides healthcare services, with a mission to preserve and optimize...
- The Medical University of South Carolina (MUSC) was awarded a $792,245 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "LEVERAGING LINEAGE ADDICTION: NUCLEAR DELIVERY OF THERAPEUTIC TRANSGENES RESPONSIVE TO ONCOGENIC TRANSCRIPTION FACTOR OVEREXPRESSION," will fund research focused on developing innovative gene therapy approaches to treat various medical conditions. The award has a performance...
- The Medical University of South Carolina (MUSC) has been awarded a $377,498 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective July 1, 2024, will support MUSC's research project titled "POPULATION-BASED ESTIMATES OF TRAUMATIC BRAIN INJURY AND SUBSEQUENT POST-TRAUMATIC EPILEPSY." The project aims to advance the scientific understanding of the relationship between traumatic brain injury and the...
- This $1,038,931 federal Project Grant was awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant funds research conducted by The Medical University of South Carolina (MUSC) to study SETD2 deficiency and its potential to increase sensitivity to BCL-XL inhibition, which may lead to new treatment approaches. The award has a performance period from September 30, 2024 to September 29, 2028. MUSC, a public university and major...
- This $1,200,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at the Medical University of South Carolina (MUSC) to target a novel adaptive stress response pathway for therapeutic intervention in alpha-synuclein-induced dementia. Through a sub-award to the Regents of the University of Minnesota, the project will utilize mouse models to provide detailed neuropathological analysis of alpha-synuclein pathology,...
- The Medical University of South Carolina (MUSC) was awarded a $1,503,880 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year grant will fund research into the function of the ARIH1 gene in epithelial-mesenchymal transition (EMT) and tumorigenesis. The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative...
- This federal Project Grant award in the amount of $906,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant titled "Defining and Targeting Cancer Cell-Intrinsic Vulnerabilities in Renal Cell Carcinoma" will be performed by the Medical University of South Carolina (MUSC) from August 1, 2024 to July 31, 2027. Through this funding, MUSC will conduct innovative biomedical research to study novel therapies...
- Federal Grant Award Summary The Medical University of South Carolina (MUSC) received a $1.19M Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on immune signatures associated with immunotherapy response in metastatic renal cell cancer. The three-year project, effective September 1, 2025 through August 31, 2028, will be performed at MUSC's Charleston, South Carolina facility. The research aims to...
- The U.S. Department of Defense (DoD) awarded a $784,963 Project Grant to the University of California, Irvine (UC Irvine) under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant, which began on September 15, 2023, funds research focused on "Interactions of Fine Particulate Matter Exposure and Gonadal Toxicity on Alzheimer's Disease Progression." UC Irvine, as a leading public research university with expertise across biomedical disciplines, will...
- Federal Grant Award Summary The Medical University of South Carolina (MUSC) received a $559,030 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 1, 2025, through July 31, 2030. This award funds basic and translational research aimed at uncovering the signaling mechanisms underlying treatment failure in medulloblastoma (MB), the...
The Medical University of South Carolina (MUSC) was awarded a $755,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on July 15, 2024, will support MUSC's research on the role of oxidative stress in heavy metal exposure-induced Alzheimer's disease. This project aims to investigate the link between environmental toxin exposure and the development of neurodegenerative disorders, with a focus on gaining a better understanding of the underlying mechanisms. The research will be conducted at MUSC's facilities in Charleston, South Carolina, and is expected to be completed by July 14, 2027. The findings from this study may contribute to the development of new preventive strategies and therapeutic interventions for Alzheimer's disease in military populations and the general public.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $755.0k | 6/5/24 |